Two cycles of ABVD followed by involved field radiotherapy with 20 Gray (Gy) is the new standard of care in the treatment of patients with early-stage Hodgkin lymphoma: final analysis of the randomized German Hodgkin Study Group (GHSG) HD10 study

被引：0
|
作者：
Engert, A.
Diehl, V [1 ]
Pluetschow, A. [1 ]
Eich, H. [2 ]
Herrmann, R. [3 ]
Doerken, B. [4 ]
Kanz, L. [5 ]
Greil, R. [6 ]
Markova, J. [8 ]
Fuchs, M. [1 ]
Borchmann, P.
Mueller-Hermeling, H. K. [7 ]
Mueller, R. P. [2 ]
机构：
[1] Innere Med Klin 1, Uniklin Koln, GHSG, Cologne, Germany
[2] Klin Strahlentherapie, Uniklin Koln, Cologne, Germany
[3] Kantonsspital Basel, Klin Onkol, Basel, Switzerland
[4] Klin Hamatol & Onkol, Charite, Berlin, Germany
[5] Univ Klin Tubingen, Klin Hamatol & Onkol, Tubingen, Germany
[6] Salzburg Univ, Innere Med Klin 3, A-5020 Salzburg, Austria
[7] Univ Wurzburg, Wurzburg, Germany
[8] Fak Nemocnice Kralovska Vinohrady, Clin Hematol, Prague, Czech Republic
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：124 / 124
页数：1
相关论文
共 50 条
  • [1] TWO CYCLES OF ABVD FOLLOWED BY INVOLVED FIELD RADIOTHERAPY WITH 20 GRAY (GY) IS THE NEW STANDARD OF CARE IN THE TREATMENT OF PATIENTS WITH EARLY-STAGE HODGKIN LYMPHOMA: FINAL ANALYSIS OF THE RANDOMIZED GERMAN HODGKIN STUDY GROUP (GHSG) HD10 STUDY
    Engert, A.
    Pluetschow, A.
    Eich, H.
    Herrmann, R.
    Doerken, B.
    Kanz, L.
    Greil, R.
    Markova, J.
    Fuchs, M.
    Borchmann, P.
    Mueller-Hermelink, H.
    Mueller, R.
    Diehl, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 473 - 473
  • [2] Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) is the New Standard of Care in the Treatment of Patients with Early Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) Trial HD10
    Mueller, R. P.
    Eich, H. T.
    Pluetschow, A.
    Debus, J.
    Bamberg, M.
    Wilbom, K.
    Eble, M.
    Mueller-Hennelink, H.
    Diehl, V.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S26 - S27
  • [3] Two Cycles of ABVD Followed by Involved Field Radiotherapy with 20 Gray (Gy) Is the New Standard of Care in the Treatment of Patients with Early-Stage Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group (GHSG) HD10.
    Engert, Andreas
    Diehl, Volker
    Pluetschow, Annette
    Eich, Hans T.
    Herrmann, Richard
    Doerken, Bernd
    Kanz, Lothar
    Greil, Richard
    Markova, Jana
    Fuchs, Michael
    Borchmann, Peter
    Mueller-Hermelink, Hans Konrad
    Mueller, Rolf Peter
    BLOOD, 2009, 114 (22) : 299 - 299
  • [4] Combined modality treatment of two or four cycles of ABVD followed by involved field radiotherapy in the treatment of patients with early stage Hodgkin's lymphoma: Update interim analysis of the randomised HD10 study of the German Hodgkin study group (GHSG).
    Engert, A
    Pluetschow, A
    Eich, HT
    Herrmann, R
    Doerken, B
    Kanz, L
    Greil, R
    Markova, J
    Pfistner, B
    Josting, A
    Mueller-Hermelink, K
    Mueller, RP
    Diehl, V
    BLOOD, 2005, 106 (11) : 750A - 750A
  • [5] TREATMENT OF PATIENTS WITH HODGKIN LYMPHOMA IN EARLY FAVOURABLE STAGES: FINAL ANALYSIS OF THE RANDOMIZED GERMAN HODGKIN STUDY GROUP (GHSG) TRIAL HD10
    Eich, H. T.
    Mueller, R. P.
    Pluetschow, A.
    Debus, J.
    Bamberg, M.
    Wilborn, K.
    Eble, M.
    Diehl, V.
    Engert, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S158 - S159
  • [6] Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's disease:: interim results of the German Hodgkin's Lymphoma Study Group (GHSG) trial hd10
    Müller, RP
    Eich, HT
    Wolf, J
    Pfistner, B
    Engert, A
    Diehl, V
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S205 - S205
  • [7] Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials
    Boell, Boris
    Goergen, Helen
    Behringer, Karolin
    Broeckelmann, Paul J.
    Hitz, Felicitas
    Kerkhoff, Andrea
    Greil, Richard
    von Tresckow, Bastian
    Eichenauer, Dennis A.
    Buerkle, Carolin
    Borchmann, Sven
    Fuchs, Michael
    Diehl, Volker
    Engert, Andreas
    Borchmann, Peter
    BLOOD, 2016, 127 (18) : 2189 - 2192
  • [8] ABVD in Older Patients With Early-Stage Hodgkin Lymphoma Treated Within the German Hodgkin Study Group HD10 and HD11 Trials
    Boell, Boris
    Goergen, Helen
    Fuchs, Michael
    Pluetschow, Annette
    Eich, Hans Theodor
    Bargetzi, Mario J.
    Weidmann, Eckhart
    Junghanss, Christian
    Greil, Richard
    Scherpe, Alexander
    Schmalz, Oliver
    Eichenauer, Dennis A.
    von Tresckow, Bastian
    Rothe, Achim
    Diehl, Volker
    Engert, Andreas
    Borchmann, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (12) : 1522 - 1529
  • [9] Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's lymphoma: Interim analysis of the German Hodgkin study group trial HDIO
    Eich, H
    Mueller, R
    Engert, A
    Hansemann, K
    Skripnitchenko, R
    Pfistner, B
    Lukas, P
    Willich, N
    Diehl, V
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S1 - S2
  • [10] Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma - An analysis of the German Hodgkin's Study Group (GHSG)
    Eich, H. T.
    Engenhart-Cabillic, R.
    Hansemann, K.
    Lukas, P.
    Seegenschmiedt, H.
    Staar, S.
    Willich, N.
    Mueller, R. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S535 - S535
12345